Table 2 A comparison of Prostap SR and Prostap 3 M with regard to reduction in pain as a percentage
(Leuprorelin acetate, 3.75 mg [12]) Prostap SR | (Leuprorelin acetate, 11.25 mg) Prostap 3M | |
|---|---|---|
Dysmenorrhoea | 98.2% | 88.5% |
Dyspareunia | 70.5% | 73.1% |
Non-menstrual pain | 70.2% | 55.1% |